5,224
Participants
Start Date
June 30, 2014
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2029
10-day bismuth-based quadruple therapy
Bismuth 300 mg (4 times a day), lansoprazole 30 mg (twice a day), metronidazole 500 mg (3 times a day), and tetracycline 500 mg (4 times a day) for 10 days
Placebo
Placebo for bismuth-based quadruple therapy
Incheon St.Mary's Hospital/The Catholic University, Incheon
Hallym University Chuncheon Sacred Heart Hospital, Chuncheon
Kosin University Gospel Hospital, Busan
Pusan National University Hospital, Busan
Kyungpook National University Hospital, Daegu
National Cancer Center, Goyang
Chonnam National University Hospital, Gwangju
Kandong Sacred Heart Hospital, Seoul
SMG-SNU Boramae Medical Center, Seoul
Chung-Ang University Hospital, Seoul
Uijeongbu St. Mary's Hospital/The Catholic University, Uijeongbu-si
International Agency for Research on Cancer
OTHER
Chonnam National University Hospital
OTHER
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
OTHER
Pusan National University Hospital
OTHER
Kyungpook National University Hospital
OTHER
Uijeongbu St. Mary's Hospital/The Catholic University
UNKNOWN
Kangdong Sacred Heart Hospital
OTHER
Incheon St.Mary's Hospital/The Catholic University
UNKNOWN
SMG-SNU Boramae Medical Center
OTHER
Chuncheon Sacred Heart Hospital
OTHER
Kosin University Gospel Hospital
OTHER
National Cancer Center, Korea
OTHER_GOV